Pesquisa | BVS Violência e Saúde

1.

Associations of birth weight, linear growth and relative weight gain throughout life with abdominal fat depots in adulthood: the 1982 Pelotas (Brazil) birth cohort study.

Araújo de França, G V; De Lucia Rolfe, E; Horta, B L; Gigante, D P; Yudkin, J S; Ong, K K; Victora, C G.

Int J Obes (Lond) ; 40(1): 14-21, 2016 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-26395747

2.

Cardiovascular and all-cause mortality in relation to various anthropometric measures of obesity in Europeans.

Song, X; Jousilahti, P; Stehouwer, C D A; Söderberg, S; Onat, A; Laatikainen, T; Yudkin, J S; Dankner, R; Morris, R; Tuomilehto, J; Qiao, Q.

Nutr Metab Cardiovasc Dis ; 25(3): 295-304, 2015 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-25315666

3.

What is innovation in the area of medicines? The example of insulin and diabetes.

Beran, D; Hirsch, I B; Yudkin, J S.

Diabet Med ; 36(12): 1526-1527, 2019 12.

Artigo em Inglês | MEDLINE | ID: mdl-31361047

4.

The insulin dilemma in resource-limited countries. A way forward?

Gill, G V; Yudkin, J S; Keen, H; Beran, D.

Diabetologia ; 54(1): 19-24, 2011 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-20835860

5.

The Diabetes UK Mozambique Twinning Programme. Results of improvements in diabetes care in Mozambique: a reassessment 6 years later using the Rapid Assessment Protocol for Insulin Access.

Beran, D; Silva Matos, C; Yudkin, J S.

Diabet Med ; 27(8): 855-61, 2010 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-20653740

6.

Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study.

Morange, P E; Saut, N; Alessi, M C; Yudkin, J S; Margaglione, M; Di Minno, G; Hamsten, A; Humphries, S E; Tregouet, D A; Juhan-Vague, I.

Arterioscler Thromb Vasc Biol ; 27(10): 2250-7, 2007 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-17656673

7.

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Fishman, D; Faulds, G; Jeffery, R; Mohamed-Ali, V; Yudkin, J S; Humphries, S; Woo, P.

J Clin Invest ; 102(7): 1369-76, 1998 Oct 01.

Artigo em Inglês | MEDLINE | ID: mdl-9769329

8.

Exercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function.

Boa, B C S; Yudkin, J S; van Hinsbergh, V W M; Bouskela, E; Eringa, E C.

Br J Pharmacol ; 174(20): 3466-3481, 2017 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-28147449

9.

Vitamin B12 deficiency and hyperhomocysteinemia in rural and urban Indians.

Yajnik, C S; Deshpande, Swapna S; Lubree, Himangi G; Naik, S S; Bhat, D S; Uradey, Bhagyashree S; Deshpande, Jyoti A; Rege, Sonali S; Refsum, Helga; Yudkin, J S.

J Assoc Physicians India ; 54: 775-82, 2006 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-17214273

10.

Using individual patient data in meta-analyses of glucose-lowering studies.

Yudkin, J S; Richter, B.

Diabetologia ; 53(1): 216-7, 2010 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-19841888

11.

Intensified glucose lowering in type 2 diabetes: time for a reappraisal.

Yudkin, J S; Richter, B; Gale, E A M.

Diabetologia ; 53(10): 2079-85, 2010 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-20686748

12.

Effect of vitamin C on glycosylation of proteins.

Davie, S J; Gould, B J; Yudkin, J S.

Diabetes ; 41(2): 167-73, 1992 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-1733805

13.

Endothelial dysfunction: cause of the insulin resistance syndrome.

Pinkney, J H; Stehouwer, C D; Coppack, S W; Yudkin, J S.

Diabetes ; 46 Suppl 2: S9-13, 1997 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-9285492

14.

Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene.

Panahloo, A; Mohamed-Ali, V; Lane, A; Green, F; Humphries, S E; Yudkin, J S.

Diabetes ; 44(1): 37-42, 1995 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-7813812

15.

Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study.

Morange, P E; Saut, N; Alessi, M C; Frere, C; Hawe, E; Yudkin, J S; Tremoli, E; Margaglione, M; Di Minno, G; Hamsten, A; Humphries, S E; Juhan-Vague, I.

Atherosclerosis ; 179(2): 317-23, 2005 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-15777548

16.

EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro.

Ireland, H; Konstantoulas, C J; Cooper, J A; Hawe, E; Humphries, S E; Mather, H; Goodall, A H; Hogwood, J; Juhan-Vague, I; Yudkin, J S; di Minno, G; Margaglione, M; Hamsten, A; Miller, G J; Bauer, K A; Kim, Y T; Stearns-Kurosawa, D J; Kurosawa, S.

Atherosclerosis ; 183(2): 283-92, 2005 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-15921688

17.

Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?

Yudkin, J S.

Diabetes Care ; 22 Suppl 3: C25-30, 1999 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-10189559

18.

Factors influencing threshold and choice of treatment for hypertension in NIDDM. Cardiovascular factors.

Yudkin, J S.

Diabetes Care ; 14 Suppl 4: 27-32, 1991 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-1748054

19.

Determinants of hospital admission and case fatality in diabetic patients with myocardial infarction.

Yudkin, J S; Oswald, G A.

Diabetes Care ; 11(4): 351-8, 1988 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-3402292

20.

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

Nagi, D K; Yudkin, J S.

Diabetes Care ; 16(4): 621-9, 1993 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-8462390

BVS Violência e Saúde

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: